Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Liabilities and Shareholders Equity of $3.0 billion for Q1 2026, up 23.73% year-over-year from $2.4 billion in Q1 2025, and up 2.15% quarter-over-quarter from $3.0 billion in Q4 2025.

Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 23.73% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $11.5 billion (up 17.88% YoY), while the FY2025 annual figure was $3.0 billion, up 19.0% from the prior year.
  • Liabilities and Shareholders Equity grew to $3.0 billion in Q1 2026 per STVN's latest filing, from $3.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.0 billion in Q1 2026 and bottomed at $1.6 billion in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $2.3 billion across 5 years, with a median of $2.4 billion in 2024.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 35.31% in 2022 and fell as far as 0.38% in 2022.
  • Stevanato Group S.p.A's Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then soared by 31.63% to $2.2 billion in 2023, then grew by 11.65% to $2.5 billion in 2024, then increased by 19.0% to $3.0 billion in 2025, then increased by 2.15% to $3.0 billion in 2026.
  • Business Quant data shows STVN's Liabilities and Shareholders Equity at $3.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $2.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn 3.04 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.04 Bn
Mar 31, 2026 3.02 Bn
Dec 31, 2025 2.96 Bn
Sep 30, 2025 2.82 Bn
Jun 30, 2025 2.66 Bn
Mar 31, 2025 2.44 Bn
Dec 31, 2024 2.49 Bn
Sep 30, 2024 2.43 Bn
Jun 30, 2024 2.37 Bn
Mar 31, 2024 2.40 Bn
Dec 31, 2023 2.23 Bn
Sep 30, 2023 2.10 Bn
Jun 30, 2023 1.97 Bn
Mar 31, 2023 1.87 Bn
Dec 31, 2022 1.69 Bn
Sep 30, 2022 1.64 Bn
Jun 30, 2022 1.64 Bn
Mar 31, 2022 1.65 Bn
Dec 31, 2021 1.62 Bn
Sep 30, 2021 1.64 Bn